The aim of this survey was to provide insight into current practice regarding the management of paediatric @entity943 in Europe. The survey was based on a questionnaire sent via the Internet to the European Heart Rhythm Association (EHRA) electrophysiology research network centres. The following topics were explored: @entity1 and treatment selection, techniques and equipment, treatment outcomes and complications. The vast majority of @entity943 @entity1 older than 1 year and @entity1 with grown-up @entity299 . In 65% of the hospitals there is a specialized paediatric centre, and the most commonly observed @entity943 include @entity3153 and @entity2917 (90.24%). The medical staff performing paediatric catheter ablations in Europe are mainly adult electrophysiology teams (82.05% of the centres). Radiofrequency is the preferred energy source used for paediatric @entity943 ablation. Catheter ablation is only chosen if two or more antiarrhythmic drugs have failed (94.59% of the centres). The majority of the centres use @entity6237 (37.8%) or @entity2165 (32.4%) as their first choice drug for prevention of recurrent @entity943 . While none of the centres performed catheter ablation in asymptomatic @entity1 with pre-excitation, 29.7% recommend ablation in asymptomatic @entity1 and adolescents. The preferred choice for pacemaker leads in @entity1 less than 1 year old is implantation of epicardial leads in 97.3% of the centres, which continues to be the routine even in @entity1 between 1 and 5 years of age as reported by 75.68% of the hospitals. Almost all centres (94.59%) report equally small number of complications of catheter ablation in @entity1 (aged 1-14 years) as observed in adults.

How are XXXX managed in the paediatric population in Europe? Results of the European Heart Rhythm survey.

@entity1 :: ('9606', 'Species') :: ['children', 'patients', 'patient', 'infants'] @entity2917 :: ('MESH:D013611', 'Disease') :: ['atrioventricular nodal re-entry tachycardias'] @entity6237 :: ('MESH:D005424', 'Chemical') :: ['flecainide'] @entity2165 :: ('MESH:D001262', 'Chemical') :: ['atenolol'] @entity299 :: ('MESH:D006331', 'Disease') :: ['congenital heart disease'] @entity3153 :: ('MESH:D014927', 'Disease') :: ['Wolff-Parkinson-White syndrome'] @entity943 :: ('MESH:D001145', 'Disease') :: ['supraventricular arrhythmias', 'paediatric arrhythmias concerns', 'arrhythmias', 'arrhythmia']
@entity943 :: (MESH:D001145,Disease) :: ['arrhythmias']
